REDWOOD CITY, California, January 23 /PRNewswire/ --
Codexis, Inc., a private biotechnology company and leading developer of clean manufacturing processes, today announced the opening of Codexis Laboratories Hungary Kft (CLH) in Budapest.
CLH, the second Codexis facility in Europe, will be a research center of excellence in fermentation strain development and process technology. It will be an expansion of the company's existing research and development operations in the US, Germany and Singapore. The laboratory will be headed by Ronen Tchelet, Ph.D., who is joining Codexis as Vice President and General Manager of CLH. Dr. Tchelet has experience in strain and technology improvement for industrial fermentation processes, combined with extensive knowledge in molecular biology. He received his bachelor's and master's degrees in biology from the Hebrew University of Jerusalem, and his Ph.D. degree in molecular microbiology and biotechnology from the Tel-Aviv University. He accomplished his post doctoral in the Swiss Federal Institute of Aquatic Science and Technology (EAWAG).
"The opening of a new facility in Central Europe is an important addition to our worldwide research organization," said Alan Shaw, Ph.D., President and CEO. "The team at CLH brings us expertise in molecular biology, strain development, and fermentation process technology. Our goal is to advance the development of new industrial fermentation processes, combining Codexis' proprietary directed evolution technologies and extensive experience with commercial fermentation process development. CLH will be a significant new facility in the growing Hungarian biotechnology community, which offers us access to a skilled employee base in an emerging European market for advanced technology."
Codexis, Inc., a clean technology company, is a leading developer of biocatalytic process technologies that can substantially reduce the cost of manufacturing across a broad range of industries. These technologies enable novel solutions for efficient, cost-effective and environmentally-friendly processes for pharmaceutical, energy and industrial chemical applications. In 2006, the U.S. EPA recognized Codexis with a Presidential Green Chemistry Challenge Award. Codexis is a registered trademark of Codexis, Inc. For more information, please visit http://www.codexis.com.
Contact: Justin Jackson, jjackson@burnsmc.com, Burns McClellan, +1-212-213-0006, or Lyn Christenson, lyn.christenson@codexis.com, +1-650-421-8144.
Web site: http://www.codexis.com
Justin Jackson of Burns McClellan, +1-212-213-0006, jjackson@burnsmc.com, for Codexis, Inc.; or Lyn Christenson of Codexis, Inc., +1-650-421-8144, lyn.christenson@codexis.com
Comments